comparemela.com

Latest Breaking News On - Bafna pharma - Page 1 : comparemela.com

Bafna Pharma Share Price, Bafna Pharma Stock Price, Bafna Pharmaceuticals Ltd Stock Price, Share Price, Live BSE/NSE, Bafna Pharmaceuticals Ltd Bids Offers Buy/Sell Bafna Pharmaceuticals Ltd news & tips, & F&O Quotes, NSE/BSE Forecast News and Live Quotes

Bafna Pharma Share Price: Find the latest news on Bafna Pharma Stock Price. Get all the information on Bafna Pharma with historic price charts for NSE / BSE. Experts & Broker view also get the Bafna Pharma Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.

stock news : Nifty 50: निफ्टी के लिए 15700 का लेवल इमीडिएट रजिस्टेंस का काम कर सकता है

these things-that-will-decide-stock-action-on-thursday-01-07-2021 Stock Tips: स्पाइसजेट, Sun Pharma, SBI Life के शेयरों में निवेश से मिलेगा मोटा मुनाफा निफ्टी (Nifty) इस समय दिशाहीन है और 15700 से 15900 के लेवल में कारोबार कर रहा है। अगर निफ्टी Nifty) 15700 से नीचे जाता है तो यह 15550 के लेवल की तरफ बढ़ सकता है। नवभारतटाइम्स.कॉम | Updated: Jul 1, 2021, 06:21AM IST नई दिल्ली घरेलू शेयर बाजार में बुधवार को गैप अप ओपनिंग देखा गया। दोपहर के कारोबार में शेयर बाजार की सुबह की सारी तेजी खत्म �

Bafna Pharma spurts after UK MHRA approval for packaging lines

Bafna Pharmaceuticals hit an upper circuit of 5% at Rs 135.15 after the UK drug regulator approved the company s two newly added automated packaging lines. In a regulatory filing made after market hours yesterday, the company said that it had added two fully automated packaging lines to its existing capacity. The aforementioned packaging lines have been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU). Commenting on the approval, Mahaveer Chand Bafna, CEO of Bafna Pharmaceuticals, said: The approval from UK- MHRA will provide further momentum to our already expanding business in the UK, Europe and other regulated markets. This approval will enable Bafna Pharma to increase its output and consequentially generate higher revenue and profits.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.